glp 1 etf Tema's Hearts & Health (HRTS) Mag7, AI and GLP-1: Roundhill

Key considerations include: Medical Conditions: Inform your doctor if you have issues like dehydration, a low-salt diet, recent diarrhea, frequent alcohol consumption, high cholesterol, elevated potassium levels, pancreatitis, chronic kidney disease or liver disease, low blood pressure, or if you are on hemodialysis

Participation is limited to clinical trial sites and eligibility requirements are determined by the trial organizers

Basu A, Charkoudian N, Schrage W, Rizza RA, Basu R, Joyner MJ

Track intake using hydration apps or bottles with time markers

GLP-1 analogues market size was exhibited at USD 18.61 billion in 2025 and is projected to be worth around USD 304.09 billion by 2035, growing at a CAGR of 32.23% from 2026 to 2036